25,437 Shares in Veeva Systems Inc. $VEEV Purchased by NEOS Investment Management LLC

NEOS Investment Management LLC purchased a new position in shares of Veeva Systems Inc. (NYSE:VEEV) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 25,437 shares of the technology company’s stock, valued at approximately $4,514,000.

Several other institutional investors also recently bought and sold shares of VEEV. SHP Wealth Management purchased a new stake in Veeva Systems in the 4th quarter worth $26,000. Arlington Trust Co LLC purchased a new position in Veeva Systems during the second quarter valued at $29,000. Field & Main Bank purchased a new position in Veeva Systems during the second quarter valued at $29,000. MV Capital Management Inc. purchased a new position in Veeva Systems during the fourth quarter valued at $30,000. Finally, Reflection Asset Management acquired a new stake in shares of Veeva Systems in the fourth quarter valued at about $32,000. 88.20% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Veeva Systems news, insider Thomas Schwenger sold 36,000 shares of the business’s stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $250.23, for a total value of $9,008,280.00. Following the transaction, the insider directly owned 19,449 shares in the company, valued at $4,866,723.27. The trade was a 64.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research firms have recently commented on VEEV. Oppenheimer boosted their target price on shares of Veeva Systems from $225.00 to $300.00 and gave the stock an “outperform” rating in a research note on Monday, August 17th. BNP Paribas Exane reiterated an “outperform” rating and issued a $285.00 price objective on shares of Veeva Systems in a report on Thursday, June 4th. Canaccord Genuity Group lifted their price objective on Veeva Systems from $220.00 to $260.00 and gave the stock a “hold” rating in a report on Thursday, August 27th. Robert W. Baird boosted their price objective on Veeva Systems from $260.00 to $300.00 and gave the stock an “outperform” rating in a research note on Thursday, August 27th. Finally, Guggenheim increased their target price on Veeva Systems from $276.00 to $310.00 and gave the company a “buy” rating in a report on Thursday, August 27th. Nineteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $284.46.

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Higher outlook and strong operating momentum: Veeva raised its fiscal 2027 outlook as Vault CRM migrations, research-and-development investment and Falcon AI adoption support revenue growth and expanding profitability. This follows a strong latest quarter, in which revenue increased 17.6% year over year to approximately $928 million and adjusted earnings exceeded analyst expectations. VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast
• Positive Sentiment: AI adoption is broadening: Regeneron and Biogen have adopted Veeva’s AI-powered Vault CRM suite globally. Veeva also introduced Falcon Safety, an agentic AI product designed for biopharmaceutical safety operations. These developments could deepen customer relationships and expand Veeva’s role in commercial and safety workflows. Why Is Veeva Systems Winning Big in AI For Biopharma?
• Positive Sentiment: Long-term investor support: Commentary highlights Veeva’s recurring-revenue model, Vault CRM migration opportunity and AI expansion as reasons the stock remains attractive for long-term growth investors. Investor Michael Burry has also reportedly remained bullish on Veeva while criticizing Snowflake’s valuation. Burry Remains Bullish on Veeva
• Neutral Sentiment: Valuation and competition remain important considerations: Analysts and portfolio commentary generally support holding VEEV, but warn that market saturation could limit future growth. With the stock trading at a premium earnings multiple after a substantial rally, investors may require continued execution and strong guidance upgrades. Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
• Negative Sentiment: Insider selling may weigh modestly on sentiment: Veeva’s exiting president sold 10,000 shares for approximately $2.8 million, representing about 51% of the executive’s direct equity stake before the transaction. The sale does not establish a change in business fundamentals, but it can raise caution after the stock’s strong advance. Veeva’s Exiting President Sold $2.8 Million in Stock

Veeva Systems Stock Down 0.4%

Shares of VEEV opened at $274.02 on Monday. Veeva Systems Inc. has a 52-week low of $148.05 and a 52-week high of $310.50. The company has a market capitalization of $44.37 billion, a PE ratio of 45.07, a price-to-earnings-growth ratio of 1.17 and a beta of 0.97. The stock has a fifty day simple moving average of $220.49 and a two-hundred day simple moving average of $188.04.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $2.23 by $0.12. Veeva Systems had a net margin of 29.34% and a return on equity of 14.25%. The firm had revenue of $927.96 million for the quarter, compared to analysts’ expectations of $905.38 million. During the same quarter in the previous year, the company posted $1.99 EPS. The company’s revenue was up 17.6% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. As a group, equities analysts anticipate that Veeva Systems Inc. will post 6.7 earnings per share for the current fiscal year.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.